Cancer Center Membership Guidelines

Cancer Center members contribute to the mission of the Center via their participation in research, including laboratory, clinical, and population- based efforts. Membership alignment is limited to one program.

Primary Criteria For Membership

  • Active cancer research as a primary professional focus
  • Interest in the application of research to improve cancer care

Learn more about membership types and categories.

HCI Membership Benefits At-a-Glance

Eligibility for:

Type 1

Type 2

Type 3

HCI Investigator Designation

X

X

X

CC Leadership

X

 

 

HCI Translational Scholar

X

 

 

Strategic Planning

X

X

 

Input on Program, Shared Resource Development

X

X

 

Program Funding

X*

X*

 

CIT Funding

X*

X*

 

CCSG Supplement Funding

X*

X*

 

Shared Resources Access

X

X

X

Clinical Research Support (cancer-focused interventional treatment trials)

X

X

X

Receipt of, or Participation in:

Funding Announcements

X

X

X

HCI Newsletter

X

X

X

Retreats/Symposia, etc.

X

X

X

*Details regarding funding opportunities can be found on the Benefits and Responsibilities page.

Cancer Center Director

Cornelia Ulrich, MS, PhD

HCI Senior Directors

Bradley R. Cairns, PhD
Basic Science
Martin McMahon, PhD
Pre-Clinical Translation
Michael W. Deininger, MD, PhD
Transdisciplinary Research
David K. Gaffney, MD, PhD
Clinical Research
Kathleen Mooney, PhD
Population Sciences
Scott Lloyd, MBA, CPA
Finance and Administration
David W. Wetter, PhD, MS
Community Engagement and Cancer Health Equity Research
Kolawole S. Okuyemi, MD, MPH
Diversity and Inclusion
Donald E. Ayer, PhD
Cancer Training Innovation

Program Leadership

 

Nuclear Control of Cell Growth and Differentiation

Brad Cairns, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader

 

Cell Response and Regulation

Sheri Holmen, PhD
Co-Leader
Alana Welm, PhD
Co-Leader

 

Experimental Therapeutics

Neeraj Agarwal, MD
Co-Leader
Martin McMahon, PhD
Co-Leader

 

Cancer Control and Population Sciences

Kathleen Mooney, PhD
Co-Leader
Sean V. Tavtigian, PhD
Co-Leader